3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
11
Cisplatin
9
Oxaliplatin
7
Leucovorin
6
Irinotecan
6
Fluorouracil
5
Taxes
3
Radiotherapy
3
Platinum
3
Interleukin-12 Subunit p35
3
Erlotinib Hydrochloride
3
Capecitabine
3
Albumin-Bound Paclitaxel
3
1,2-diaminocyclohexaneplatinum II citrate
3
Trastuzumab
2
Docetaxel
2
Cyclophosphamide
2
Carboplatin
2
130-nm albumin-bound paclitaxel
2
tipifarnib
1
sargramostim
1
pembrolizumab
1
motexafin gadolinium
1
merestinib
1
guadecitabine
1
fludarabine
1
entinostat
1
durvalumab
1
dehydroftorafur
1
aldesleukin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Gallbladder Neoplasms
×
NUC-1031
×
Clear all
NCT02351765
2023-05-17
ABC-08
The Christie NHS Foundation Trust
Phase 1
Completed
21 enrolled